L
Market Data
$15.49+$2.86 (+22.64%)
LYEL · Last trade
Prev Close
$12.63
Range (29d)
$12.87 – $15.79
Recent Filings
- SCHEDULE 13G/A21.4 KBLyell Immunopharma, Inc.Aug 14, 4:03 PM ET·0001104659-26-097073
- 10-Q11.4 MBLyell Immunopharma, Inc.Aug 6, 4:27 PM ET·0001628280-26-054367
- 8-K321.8 KBLyell Immunopharma, Inc.Aug 6, 4:14 PM ET·0001628280-26-054330
- 8-K147.6 KBLyell Immunopharma, Inc.Jun 15, 4:05 PM ET·0001193125-26-271071
- 10-Q10.5 MBLyell Immunopharma, Inc.May 6, 4:14 PM ET·0001628280-26-031284
- 8-K291.0 KBLyell Immunopharma, Inc.May 6, 4:10 PM ET·0001628280-26-031269
- 10-K18.8 MBLyell Immunopharma, Inc.Mar 12, 4:16 PM ET·0001628280-26-017253
- 8-K291.4 KBLyell Immunopharma, Inc.Mar 12, 4:12 PM ET·0001628280-26-017244
- 8-K200.9 KBLyell Immunopharma, Inc.Mar 9, 8:05 AM ET·0001193125-26-097615
- 8-K145.5 KBLyell Immunopharma, Inc.Dec 8, 6:02 AM ET·0001193125-25-310469
Insiders
10- Albertson Tina M.Chief Medical Officer
- ARCH Venture Fund IX, L.P.10% Owner
- ARCH Venture Fund XIII, L.P.10% Owner
- ARCH Venture Partners IX, LLC10% Owner
- ARCH Venture Partners IX, L.P.10% Owner
- Bachleda MarkDirector
- BERNS PAUL L10% Owner
- Bishop Hans EdgarDirector
- BRAWLEY OTIS WDirector
- Bulis Veronica SanchezVP, Corporate Controller
Tickers
Addresses
business
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA, 94080
mailing
201 HASKINS WAY
SOUTH SAN FRANCISCO, CA, 94080